Active ingredients commonly used in nutraceuticals and cosmeceuticals originate from a diverse, complex and rich group of molecules found in nature. A multitude of studies have shown that they offer solutions to a wide range of conditions/problems but at the same time they are plagued with a series of issues, the main one being very low bioavailability. If bioavailability is low, then the health/cosmetic outcome (for the consumer) is also low or even non-existent. This leads to low repeat business or even, brand awareness for the wrong reasons … “XXXXX products didn’t do anything for me.”
Advanced delivery systems can help solve this problem and, when developed /applied properly, they can offer supercharged bioavailability to your existing interesting ingredients. We will explore the features of tiny structures, such as micelles and liposomes, and why they are very efficient at delivering active ingredients to the bloodstream, and what this means to both the manufacturer and consumer.
Join this webinar to learn about the various solutions available to you, and how Pharmako’s advanced technologies can help you unlock your ingredient’s potential to get the best out of your products.
When you attend this webinar, you will:
- walk away with an overview of the types of advanced delivery systems;
- learn how and why to apply delivery systems technologies to your ingredients;
- discover the science there is to support their efficacy; and
- see how choosing Pharmako ingredients enables you offer your customers products of innovation, science and true value.
George Kokkinis, Director / Co-founder, Pharmako Biotechnologies
George Kokkinis is the Director and co-founder of Pharmako Biotechnologies, and developer of a number of the technologies used in Pharmako's products. With 30 years’ experience, he has extensive industry knowledge. Working across the Theraputic Goods Administration (TGA) for nearly 10 years, general manager of both, a Therapeutic Goods Regulatory Consulting firm managing a large client portfolio, and then a brand company where he was challenged to modernise the manufacturing arm, introduce new product development, regulatory & expand business development. George now coordinates all technical aspects of Pharmako with a keen interest in new delivery technologies, clinicals and advanced manufacturing methods.
Eric Meppem, Co-founder and Commercial Director, Pharmako Biotechnologies
Eric Meppem is the Co-founder and commercial director of Pharmako Biotechnologies. With a legal background and experience in sports marketing and health & fitness for over 20 years , he has specialised in innovation from product, material and marketing perspectives in the nutraceutical industry. His extensive experience across FMCG, wholesale, retail, manufacturing, supply, and customer insights include senior positions at Pharmacare Laboratories and Swiss Wellness (now H&H Group).